{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:53:06Z","timestamp":1740106386357,"version":"3.37.3"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cyto.2024.156792","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T19:57:23Z","timestamp":1730577443000},"page":"156792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diphencyprone reduces the CD8+\u00a0lymphocytes and IL-4 and enhences IgG2a\/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB\/c mice"],"prefix":"10.1016","volume":"184","author":[{"given":"Pourandokht","family":"Mousavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Mashayekhi Goyonlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Javanbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Reza Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Moosavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monovar","family":"Afzal Aghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A Review of Leishmaniasis: Current Knowledge and Future Directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr Trop Med Rep."},{"key":"10.1016\/j.cyto.2024.156792_b0010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4314\/ahs.v22i3.68","article-title":"Leishmaniasis prevalence, awareness and control in Saudi Arabia","volume":"22","author":"Kumosani","year":"2022","journal-title":"Afr Health Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and Economic Burden of Human Leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.cyto.2024.156792_b0025","doi-asserted-by":"crossref","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: Recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2023","journal-title":"Front Microbiol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.cyto.2024.156792_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.685296","article-title":"Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)","volume":"11","author":"Volpedo","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"issue":"976","key":"10.1016\/j.cyto.2024.156792_b0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/pgmj.2006.047340corr1","article-title":"Leishmaniasis","volume":"83","author":"Piscopo","year":"2007","journal-title":"Postgrad Med J."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4269\/ajtmh.13-0376","article-title":"Bone marrow parasite burden among patients with New World kala-azar is associated with disease severity","volume":"90","author":"Silva","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.cyto.2024.156792_b0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003053","article-title":"Determinants for the development of visceral leishmaniasis disease","volume":"9","author":"McCall","year":"2013","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.cyto.2024.156792_b0060","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/microorganisms10101887","article-title":"Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics","volume":"10","author":"Scarpini","year":"2022","journal-title":"Microorganisms."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasit Vectors."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0070","doi-asserted-by":"crossref","first-page":"e02851","DOI":"10.7554\/eLife.02851","article-title":"Global distribution maps of the leishmaniases","volume":"27","author":"Pigott","year":"2014","journal-title":"Elife."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/21505594.2022.2074130","article-title":"The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses","volume":"13","author":"Gupta","year":"2022","journal-title":"Virulence."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/tropicalmed7040054","article-title":"Immune Responses in Leishmaniasis: An Overview","volume":"7","author":"Costa-da-Silva","year":"2022","journal-title":"Trop Med Infect Dis."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0085","doi-asserted-by":"crossref","first-page":"e0011875","DOI":"10.1371\/journal.pntd.0011875","article-title":"The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case","volume":"18","author":"Riebenbauer","year":"2024","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.cyto.2024.156792_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155322","article-title":"Cytokine saga in visceral leishmaniasis","volume":"147","author":"Bhor","year":"2021","journal-title":"Cytokine."},{"issue":"10151","key":"10.1016\/j.cyto.2024.156792_b0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.cyto.2024.156792_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpubh.2020.00011","article-title":"The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review","volume":"8","author":"Ghatee","year":"2020","journal-title":"Front Public Health."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00281-020-00796-y","article-title":"Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases","volume":"42","author":"Alvar","year":"2020","journal-title":"Semin Immunopathol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156792_b0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-3024.2006.00886.x","article-title":"The immunology of parasite infections in immunocompromised hosts","volume":"28","author":"Evering","year":"2006","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2020.100046","article-title":"Humoral immunity in leishmaniasis - Prevention or promotion of parasite growth?","volume":"2","author":"Goncalves","year":"2020","journal-title":"Cytokine X."},{"key":"10.1016\/j.cyto.2024.156792_b0120","doi-asserted-by":"crossref","first-page":"1063291","DOI":"10.3389\/fcimb.2022.1063291","article-title":"Humoral response in Leishmaniasis","volume":"12","author":"Conde","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156792_b0125","doi-asserted-by":"crossref","first-page":"e0004273","DOI":"10.1371\/journal.pntd.0004273","article-title":"Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis","volume":"9","author":"Rosales-Chilama","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.cyto.2024.156792_b0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","article-title":"T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant?","volume":"3","author":"Alexander","year":"2012","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0135","first-page":"43","article-title":"Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis","volume":"1","author":"Shahi","year":"2013","journal-title":"Rep Biochem Mol Biol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156792_b0140","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4020::AID-IMMU4020>3.0.CO;2-3","article-title":"Parasite dose determines the Th1\/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite","volume":"28","author":"Menon","year":"1998","journal-title":"Eur J Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156792_b0145","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/iai.62.9.3655-3662.1994","article-title":"Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response","volume":"62","author":"Nabors","year":"1994","journal-title":"Infect Immun."},{"issue":"12","key":"10.1016\/j.cyto.2024.156792_b0150","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1286-4579(00)01298-3","article-title":"Different cytokines are required for induction and maintenance of the Th2 type response in DBA\/2 mice resistant to infection with Leishmania major","volume":"2","author":"Nashed","year":"2000","journal-title":"Microbes Infect."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0155","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J Exp Med."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","article-title":"Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review","volume":"110","author":"Maspi","year":"2016","journal-title":"Pathog Glob Health."},{"issue":"12","key":"10.1016\/j.cyto.2024.156792_b0165","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/eji.1830251215","article-title":"In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-","volume":"25","author":"Launois","year":"1995","journal-title":"Eur J Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00281-015-0475-7","article-title":"CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly","volume":"37","author":"Novais","year":"2015","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.cyto.2024.156792_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","article-title":"CD8(+) T cells in leishmania infections: friends or foes?","volume":"3","author":"St\u00e4ger","year":"2012","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0180","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4049\/jimmunol.151.4.2077","article-title":"Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis","volume":"151","author":"Wang","year":"1993","journal-title":"J Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156792_b0185","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/IAI.66.8.3968-3970.1998","article-title":"Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice","volume":"66","author":"Huber","year":"1998","journal-title":"Infect Immun."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/120347540200600303","article-title":"The use of diphenylcyclopropenone in the treatment of recalcitrant warts","volume":"6","author":"Upitis","year":"2002","journal-title":"J Cutan Med Surg."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jso.23506","article-title":"Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma","volume":"109","author":"Damian","year":"2014","journal-title":"J Surg Oncol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0200","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/1346-8138.16688","article-title":"Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin","volume":"50","author":"Han","year":"2023","journal-title":"J Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156792_b0205","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jdcr.2018.07.003","article-title":"Anaphylaxis to diphenylcyclopropenone during sensitization for wart treatment-A case report","volume":"4","author":"Venkatesh","year":"2018","journal-title":"JAAD Case Rep."},{"issue":"10","key":"10.1016\/j.cyto.2024.156792_b0210","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/jid.2014.196","article-title":"Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights","volume":"134","author":"Gulati","year":"2014","journal-title":"J Invest Dermatol."},{"issue":"5\u20136","key":"10.1016\/j.cyto.2024.156792_b0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasy\u0142yszyn","year":"2007","journal-title":"Arch Dermatol Res."},{"issue":"12","key":"10.1016\/j.cyto.2024.156792_b0220","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/jid.2012.212","article-title":"The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model","volume":"132","author":"Lehtim\u00e4ki","year":"2012","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.cyto.2024.156792_b0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-4894(90)90039-F","article-title":"Leishmania major and L. donovani: a method for rapid purification of amastigote","volume":"71","author":"Glaser","year":"1990","journal-title":"Exp Parasitol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jidsymp.2015.33","article-title":"Diphencyprone Treatment of Alopecia Areata: Postulated Mechanism of Action and Prospects for Therapeutic Synergy with RNA Interference","volume":"17","author":"Bulock","year":"2015","journal-title":"J Investig Dermatol Symp Proc."},{"issue":"5","key":"10.1016\/j.cyto.2024.156792_b0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20030159","article-title":"Interleukin 1\u03b1 promotes Th(1) differentiation and inhibits disease progression in Leishmania major \u2013 susceptible BALB\/c mice","volume":"198","author":"von Stebut","year":"2003","journal-title":"J Exp Med."},{"issue":"11","key":"10.1016\/j.cyto.2024.156792_b0245","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol."},{"issue":"16","key":"10.1016\/j.cyto.2024.156792_b0250","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.3390\/ijms23169306","article-title":"TNF-\u03b1 Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2","volume":"23","author":"Pesce","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"7","key":"10.1016\/j.cyto.2024.156792_b0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/506624","article-title":"Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis","volume":"194","author":"Ansari","year":"2006","journal-title":"J Infect Dis."},{"issue":"5","key":"10.1016\/j.cyto.2024.156792_b0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156792_b0265","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/tropicalmed8050276","article-title":"Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization","volume":"8","author":"Almeida","year":"2023","journal-title":"Trop Med Infect Dis."},{"key":"10.1016\/j.cyto.2024.156792_b0270","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3389\/fmicb.2020.01986","article-title":"Modulation of Cytokines and Extracellular Matrix Proteins Expression by Leishmania amazonensis in Susceptible and Resistant Mice","volume":"11","author":"Cardoso","year":"2020","journal-title":"Front Microbiol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0275","doi-asserted-by":"crossref","first-page":"e15055","DOI":"10.1016\/j.heliyon.2023.e15055","article-title":"The cytokine\/chemokine response in Leishmania\/HIV infection and co-infection","volume":"9","author":"Maksoud","year":"2023","journal-title":"Heliyon."},{"key":"10.1016\/j.cyto.2024.156792_b0280","doi-asserted-by":"crossref","first-page":"2496713","DOI":"10.1155\/2020\/2496713","article-title":"Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection","volume":"2020","author":"Dubie","year":"2020","journal-title":"J Immunol Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.143.1.266","article-title":"Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H\/HeN mice to infection with Leishmania major","volume":"143","author":"Belosevic","year":"1989","journal-title":"J Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80435-5","article-title":"Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity","volume":"4","author":"Kamanaka","year":"1996","journal-title":"Immunity."},{"key":"10.1016\/j.cyto.2024.156792_b0295","doi-asserted-by":"crossref","first-page":"1414493","DOI":"10.3389\/fcimb.2024.1414493","article-title":"The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGF\u03b2","volume":"14","author":"Na","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0300","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","article-title":"A natural model of Leishmania major infection reveals a prolonged \u201csilent\u201d phase of parasite amplification in the skin before the onset of lesion formation and immunity","volume":"165","author":"Belkaid","year":"2000","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2024.156792_b0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12879-014-0653-6","article-title":"Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals","volume":"14","author":"Kaushal","year":"2014","journal-title":"BMC Infect Dis."},{"issue":"8","key":"10.1016\/j.cyto.2024.156792_b0310","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156792_b0315","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/eji.1830171007","article-title":"Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis","volume":"17","author":"Titus","year":"1987","journal-title":"Eur J Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156792_b0320","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis","volume":"31","author":"Faria","year":"2009","journal-title":"Parasite Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0325","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/jid.2013.4","article-title":"CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFN\u03b3(+)-mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"da Silva Santos","year":"2013","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.cyto.2024.156792_b0330","first-page":"165","article-title":"The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis","volume":"2","author":"da Silva","year":"2014","journal-title":"Front Public Health."},{"issue":"8","key":"10.1016\/j.cyto.2024.156792_b0335","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.cyto.2024.156792_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2023.102738","article-title":"Pathological roles of macrophages in Leishmania infections","volume":"94","author":"Goto","year":"2023","journal-title":"Parasitol Int."},{"issue":"3","key":"10.1016\/j.cyto.2024.156792_b0345","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.184.3.1127","article-title":"IL-4-deficient Balb\/c mice resist infection with Leishmania major","volume":"184","author":"Kopf","year":"1996","journal-title":"J Exp Med."},{"issue":"11","key":"10.1016\/j.cyto.2024.156792_b0350","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni725","article-title":"IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice","volume":"2","author":"Biedermann","year":"2001","journal-title":"Nat Immunol."},{"key":"10.1016\/j.cyto.2024.156792_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759021","article-title":"Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection","volume":"12","author":"Osero","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2024.156792_b0360","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fcimb.2019.00479","article-title":"Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of Leishmania major in Mice","volume":"9","author":"Hurdayal","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmii.2015.05.007","article-title":"Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice","volume":"50","author":"Rostamian","year":"2017","journal-title":"J Microbiol Immunol Infect."},{"issue":"1","key":"10.1016\/j.cyto.2024.156792_b0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3347\/kjp.2006.44.1.43","article-title":"Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice","volume":"44","author":"Mohammadi","year":"2006","journal-title":"Korean J Parasitol."},{"key":"10.1016\/j.cyto.2024.156792_b0375","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/181690","article-title":"BALB\/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge","volume":"2010","author":"Ram\u00edrez","year":"2010","journal-title":"J Biomed Biotechnol."},{"key":"10.1016\/j.cyto.2024.156792_b0380","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2019.01957","article-title":"IL-4 Mediated Resistance of BALB\/c Mice to Visceral Leishmaniasis Is Independent of IL-4R\u03b1 Signaling via T Cells","volume":"10","author":"McFarlane","year":"2019","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156792_b0385","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003476","article-title":"T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0395","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jid.2020.04.033","article-title":"Induction of Regulatory T Cells in Leishmania major-Infected BALB\/c Mice Does Not Require Langerin+ Dendritic Cells","volume":"141","author":"Lukas","year":"2021","journal-title":"J Invest Dermatol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156792_b0400","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.181.7.4613","article-title":"T cells from Leishmania major-susceptible BALB\/c mice have a defect in efficiently up-regulating CXCR3 upon activation","volume":"181","author":"Barbi","year":"2008","journal-title":"J Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156792_b0405","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0624","article-title":"CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases","volume":"3","author":"Valencia","year":"2007","journal-title":"Nat Clin Pract Rheumatol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156792_b0410","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand J Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med."},{"issue":"6","key":"10.1016\/j.cyto.2024.156792_b0420","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.1400728","article-title":"The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection","volume":"193","author":"Ehrlich","year":"2014","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2024.156792_b0425","doi-asserted-by":"crossref","first-page":"1304696","DOI":"10.3389\/fimmu.2024.1304696","article-title":"Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis","volume":"15","author":"Nateghi-Rostami","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2024.156792_b0430","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasit Vectors."},{"issue":"2","key":"10.1016\/j.cyto.2024.156792_b0435","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imbio.2008.07.001","article-title":"Identification of regulatory T cells during experimental Leishmania infantum infection","volume":"214","author":"Rodrigues","year":"2009","journal-title":"Immunobiology."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T23:29:52Z","timestamp":1731972592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":87,"alternative-id":["S1043466624002965"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156792","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diphencyprone reduces the CD8+\u00a0lymphocytes and IL-4 and enhences IgG2a\/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156792"}}